Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control

JAMA Ophthalmology Author Interviews
13/07/2023 13 min
Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control

Listen "Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control"

Descargar episodio Ver en sitio original

Episode Synopsis

Interview with Michael X. Repka, MD, MBA, author of Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control: A Randomized Clinical Trial. Hosted by Neil Bressler, MD. Related Content: Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control

More episodes of the podcast JAMA Ophthalmology Author Interviews

Aflibercept Dose in Polypoidal Choroidal Vasculopathy 18/12/2025
The Central Role of Home Hazards in Shaping the Association of Visual Function and Falls in Older Adults 11/12/2025
Foundation Models vs Physicians in Ophthalmological Questions 13/11/2025
Retinal Sensitivity and Retinal Perfusion in Diabetic Retinopathy 30/10/2025
Diabetes in the Donor and Descemet Membrane Endothelial Keratoplasty Success at 1 Year 17/10/2025
Smooth Pursuit Velocity After a Season of Repetitive Head Impacts in American Football Players 18/09/2025
Mammalian Target Rapamycin Inhibition for Proliferative Vitreoretinopathy 07/08/2025
Steroids and Cross-Linking for Ulcer Treatment 24/07/2025
From the JAMA Network: GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension 17/07/2025
Gender Differences in Case Volume Among Ophthalmology Resident Graduates, 2014-2023 01/05/2025
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA